Humanigen Accounts Payable

Humanigen (HGEN) currently reports a accounts payable of $38M as of March 2023. That compares with $48M in the prior-year period — down 19.8% year over year. Use the charts on this page to explore Humanigen's accounts payable history and peer comparisons.

Humanigen's accounts payable decreased from $48M to $38M — a 19.8% year-over-year decrease (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Humanigen reported $38M in accounts payable as of March 2023. That compares with $48M in the prior-year period — down 19.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $38M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Humanigen, and consider following HGEN for alerts when major investors trade the stock.

Humanigen is classified in the Healthcare sector. On accounts payable, it currently shows $38M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HGEN with unrelated industries.